Concepedia

Daniel M.F. Claassens

DM

8

Publications

765

Citations

8

H-Index

2017

Active since

Affiliations

University Medical Center Utrecht(Current)

St. Antonius Ziekenhuis

University College London

Isala

OLVG

Daniel M.F. Claassens is an author at University Medical Center Utrecht specializing in cardiovascular disease, medicine, and public health.

ORCID

Top concepts

Publications per year

2017–2021

8

Publications

8

A Genotype-Guided Strategy for Oral P2Y <sub>12</sub> Inhibitors in Primary PCI

Daniel M.F. Claassens, Gerrit J.A. Vos, Thomas O. Bergmeijer et al. · New England Journal of Medicine · 2019 · 597 citations · Full text

Perioperative management of antiplatelet treatment in patients undergoing isolated coronary artery bypass grafting in Dutch cardiothoracic centres

Paul W.A. Janssen, Daniel M.F. Claassens, Laura M. Willemsen et al. · Netherlands Heart Journal · 2017 · 33 citations · Full text

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial

Daniel M.F. Claassens, Pim W. M. van Dorst, Gerrit J.A. Vos et al. · American Journal of Cardiovascular Drugs · 2021 · 27 citations · Full text

, , +10

Feasibility and Implementation of <i>CYP2C19</i> Genotyping in Patients Using Antiplatelet Therapy

Thomas O. Bergmeijer, Gerrit J.A. Vos, Daniel M.F. Claassens et al. · Pharmacogenomics · 2018 · 26 citations · Full text

Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype

Daniel M.F. Claassens, Thomas O. Bergmeijer, Gerrit J.A. Vos et al. · Circulation Cardiovascular Interventions · 2021 · 26 citations · Full text

Rows per page

1–5 of 8